ClinicalTrials.gov
ClinicalTrials.gov Menu

Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00348166
Recruitment Status : Withdrawn (Stringent eligibility criterion caused difficulties in recruiting patients.)
First Posted : July 4, 2006
Last Update Posted : October 5, 2011
Sponsor:
Information provided by:
KK Women's and Children's Hospital

Brief Summary:
The purpose of this study is to find out if undercorrection of myopia slow down the progression of myopia in kindergarten children.

Condition or disease Intervention/treatment Phase
Refractive Error - Myopia Drug: cyclopentolate Phase 1

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 180 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double
Official Title: Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten
Study Start Date : December 2005
Actual Primary Completion Date : June 2008
Actual Study Completion Date : June 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years to 6 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Children of chinese descent aged 5 - 6yrs
  2. Refractive error of -1.00 to -3.00Ds
  3. Less than 1.50 astigmatism in each eye. (No oblique axis)
  4. Visual acuity is 6/6 or better in both eyes.
  5. No binocular problems, no anisometropia >1.50D
  6. Will be staying in S'pore for at least 2 years.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00348166


Sponsors and Collaborators
KK Women's and Children's Hospital
Investigators
Principal Investigator: Quah Boon Long Singapore National Eye Centre

ClinicalTrials.gov Identifier: NCT00348166     History of Changes
Other Study ID Numbers: RAU/085/2005
First Posted: July 4, 2006    Key Record Dates
Last Update Posted: October 5, 2011
Last Verified: October 2011

Additional relevant MeSH terms:
Myopia
Refractive Errors
Eye Diseases
Cyclopentolate
Mydriatics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Parasympatholytics
Muscarinic Antagonists
Cholinergic Antagonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action